Shannon Morris - 10 Apr 2023 Form 4 Insider Report for Erasca, Inc. (ERAS)

Role
Chief Medical Officer
Signature
/s/ Shannon Morris
Issuer symbol
ERAS
Transactions as of
10 Apr 2023
Net transactions value
$0
Form type
4
Filing time
13 Apr 2023, 20:26:29 UTC
Next filing
07 Feb 2024
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ERAS Stock Option (Right to Buy) Award $0 +375,000 $0.000000 375,000 10 Apr 2023 Common Stock 375,000 $2.74 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 1/48th of the shares subject to the option vest monthly following April 10, 2023, subject to the Reporting Person's continuous service to the Issuer on each such vesting date.